However such a piece of equipment is not limited to Dr Gedye’s research.
A triple-gas incubator will assist:
• breast cancer,
• prostate cancer,
• endometrial, ovarian and testicular cancer researchers,
• leukemia and brain cancer researchers, as well as,
• Inflammatory bowel disease researchers within HMRI.
Dr Gedye’s basic laboratory research within the HMRI Building will focus on ways of targeting these more aggressive kidney cancer cells, and hopefully lead to novel combinations of old and new drugs to work with the medications routinely used in the clinic.